Bortezomib-based treatment for multiple myeloma patients with renal impairment: A systematic review and meta-analysis of observational studies

by Zhu, Wanqiu, Chen, Wenming
Published 2016

Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer

by Yan, Dong, Wei, Ping, An, Guangyu, Chen, Wenming
Published 2013

Significance of p85 expression as a prognostic factor for patients with breast cancer

by ZHOU, WEIWEI, AN, GUANGYU, WEI, PING, CHEN, WENMING
Published 2014

Multiple myeloma with extramedullary plasmacytoma invading the skin and eyeballs following autologous stem cell transplantation: A case report

by YANG, GUANGZHONG, GENG, CHUANYING, LI, YANCHEN, LIU, AIJUN, CHEN, WENMING
Published 2013

Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization

by Hu, Ying, Chen, Wenming, Chen, Shilun, Huang, Zhongxia
Published 2016

Gefitinib upregulates death receptor 5 expression to mediate rmhTRAIL-induced apoptosis in Gefitinib-sensitive NSCLC cell line

by Yan, Dong, Ge, Yang, Deng, Haiteng, Chen, Wenming, An, Guangyu
Published 2015

Surgical treatment of refractory epilepsy after chemotherapy in two children with leukemia☆

by Leng, Yun, Yu, Tao, Li, Yongjie, Chen, Wenming
Published 2013

Comparison of survival of patients receiving laparoscopic and open radical resection for stage II colon cancer

by Fan, Cui-Zhen, Chu, Yu-Ping, Wei, Ping, Dai, Hong, Chen, Wenming
Published 2011

Developmental Status: Impact of Short-Term Ischemia on Follicular Survival of Whole Ovarian Transplantation in a Rabbit Model

by Xie, Shuangshuang, Zhang, Xing, Chen, Wenming, Xie, Chichi, Chen, Wenwei, Cheng, Pu, Zhou, Ying, Chen, Bicheng
Published 2015

More frequent IgD and reduced CD200 expression in Chinese patients younger than 50 years old with multiple myeloma: a multicenter analysis

by Lu, Jin, Lu, Jing, Chen, Wenming, Wang, Jing, Huo, Yuliang, Hou, Jian, Huang, Xiaojun
Published 2016

Prognostic Impact of Cytogenetic Abnormalities in Multiple Myeloma: A Retrospective Analysis of 229 Patients

by Jian, Yuan, Chen, Xiaolei, Zhou, Huixing, Zhu, Wanqiu, Liu, Nian, Geng, Chuanying, Chen, Wenming
Published 2016

The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicent...

by Lu, Jing, Lu, Jin, Liu, Aijun, Fu, Weijun, Du, Juan, Huang, Xiaojun, Chen, Wenming, Hou, Jian
Published 2015

Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma

by LIU, NIAN, ZHOU, HEBING, YANG, GUANGZHONG, GENG, CHUANYING, JIAN, YUAN, GUO, HUAN, CHEN, WENMING
Published 2015

Retrospective analysis of 264 multiple myeloma patients

by GENG, CHUANYING, LIU, NIAN, YANG, GUANGZHONG, LIU, AIJUN, LENG, YUN, WANG, HUIJUAN, LI, LIHONG, WU, YIN, LI, YANCHEN, CHEN, WENMING
Published 2013

Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma

by Leng, Yun, Qiu, Lugui, Hou, Jian, Zhao, Yaozhong, Zhang, Xuejun, Yang, Shifang, Xi, Hao, Huang, Zhongxia, Pan, Ling, Chen, Wenming
Published 2016

E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs

by Zhang, Erbao, Yin, Dandan, Han, Liang, He, Xuezhi, Si, Xinxin, Chen, Wenming, Xia, Rui, Xu, Tongpeng, Gu, Dongying, De, Wei, Guo, Renhua, Xu, Zhi, Chen, Jinfei
Published 2015

Improved Response Rates with Bortezomib in Relapsed or Refractory Multiple Myeloma: An Observational Study in Chinese Patients

by Lin, MaoFang, Hou, Jian, Chen, WenMing, Huang, XiaoJun, Liu, ZhuoGang, Zhou, YuHong, Li, Yan, Zhao, Taiyun, Wang, LinNa, Wu, Kwang-Wei, Shen, ZhiXiang
Published 2014